Related references
Note: Only part of the references are listed.Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
Tom Z. Yuan et al.
MABS (2022)
Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus
Gregory Gaich et al.
DIABETES (2022)
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
Toon Laeremans et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Impact of the Human Cell Atlas on medicine
Jennifer E. Rood et al.
NATURE MEDICINE (2022)
Pathophysiological impact of the adhesion G protein-coupled receptor family
Jeanette M. Einspahr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)
Designing antibodies as therapeutics
Paul J. Carter et al.
CELL (2022)
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody
Jessica D. Weaver et al.
ONCOIMMUNOLOGY (2022)
Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain
Jiyong Meng et al.
NATURE CHEMICAL BIOLOGY (2022)
OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus
Sanela Bilic et al.
Journal of the Endocrine Society (2022)
Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4
Shuai Hao et al.
BMC CANCER (2022)
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])
Julien Carvelli et al.
CRITICAL CARE MEDICINE (2022)
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
Jeremy Pettus et al.
NATURE MEDICINE (2022)
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform
Dirk H. Siepe et al.
ELIFE (2022)
Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle
Judit Sanchez Gil et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Chimeric efferocytic receptors improve apoptotic cell clearance and alleviate inflammation
Sho Morioka et al.
CELL (2022)
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR x LGR5 bispecific antibody with efficacy in epithelial tumors
Bram Herpers et al.
NATURE CANCER (2022)
RTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal development
Jie Wang et al.
CELL (2021)
Autoantibodies as Endogenous Modulators of GPCR Signaling
Meredith A. Skiba et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Helena Van Damme et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
In vitro profiling of orphan G protein coupled receptor (GPCR) constitutive activity
Lyndsay R. Watkins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models
Joseph R. Campbell et al.
CANCER RESEARCH (2021)
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
Sarah K. Whiteside et al.
IMMUNOLOGY (2021)
Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution
C. Trilleaud et al.
SCIENCE ADVANCES (2021)
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
Christie P. M. Verkleij et al.
BLOOD ADVANCES (2021)
Rapid generation of potent antibodies by autonomous hypermutation in yeast
Alon Wellner et al.
NATURE CHEMICAL BIOLOGY (2021)
A single-cell type transcriptomics map of human tissues
Max Karlsson et al.
SCIENCE ADVANCES (2021)
A human antibody against human endothelin receptor type A that exhibits antitumor potency
Man-Seok Ju et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
Shu-Chen Lu et al.
CELL REPORTS MEDICINE (2021)
Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control
Qiang Liu et al.
MABS (2021)
Activation of a G protein-coupled receptor through indirect antibody-mediated tethering of ligands
Ross W. Cheloha et al.
RSC CHEMICAL BIOLOGY (2021)
Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody
Catarina Cunha-Santos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Novel approaches leading towards peptide GPCR de-orphanisation
Alexander S. Hauser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Structure-guided discovery of a single-domain antibody agonist against human apelin receptor
Yanbin Ma et al.
SCIENCE ADVANCES (2020)
Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab)
Fernando Garces et al.
CELL REPORTS (2020)
A review of antibody-based therapeutics targeting G protein-coupled receptors: an update
Catherine J. Hutchings
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen et al.
NATURE CHEMICAL BIOLOGY (2020)
The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome
Erik Verschueren et al.
CELL (2020)
A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions
Woj M. Wojtowicz et al.
CELL (2020)
Synthetic nanobodies as angiotensin receptor blockers
Conor McMahon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Conformational Basis of G Protein-Coupled Receptor Signaling Versatility
Laura M. Wingler et al.
TRENDS IN CELL BIOLOGY (2020)
Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
Mark Soave et al.
CELL CHEMICAL BIOLOGY (2020)
Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects
Hongchao Pan et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2020)
Therapeutic Monoclonal Antibody Antagonizing Endothelin Receptor A for Pulmonary Arterial Hypertension
Cheng Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
Timo W. M. De Groof et al.
MOLECULAR PHARMACEUTICS (2019)
Light-activated chimeric GPCRs: limitations and opportunities
Alexandra-Madelaine Tichy et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology
Henry A. Dunn et al.
PHARMACOLOGICAL REVIEWS (2019)
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
Maria Jose Costa et al.
SCIENTIFIC REPORTS (2019)
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor
Chadwick Terence King et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2019)
A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β1-adrenoceptors expressed in stable cell lines
Mark Soave et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites
Caina Li et al.
BIOCHEMICAL PHARMACOLOGY (2018)
BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation
Dan Zhu et al.
CANCER CELL (2018)
Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial
Jeremy Pettus et al.
DIABETES OBESITY & METABOLISM (2018)
The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth
Raimond Heukers et al.
ONCOGENE (2018)
Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity
Chun-Rong Chen et al.
THYROID (2018)
The Molecular Basis of G Protein-Coupled Receptor Activation
William I. Weis et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
Elizabeth A. Killion et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Olfactory, Taste, and Photo Sensory Receptors in Non-sensory Organs: It Just Makes Sense
Nicholas M. Dalesio et al.
FRONTIERS IN PHYSIOLOGY (2018)
A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers
Ana Kostic et al.
DIABETES OBESITY & METABOLISM (2018)
Pooled extracellular receptor-ligand interaction screening using CRISPR activation
Zheng-Shan Chong et al.
GENOME BIOLOGY (2018)
Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody
Andrii Ishchenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation
Pauline Scholler et al.
NATURE COMMUNICATIONS (2017)
Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
Sheng-Bin Peng et al.
ONCOTARGET (2017)
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
Marcus M. Fischer et al.
SCIENCE ADVANCES (2017)
Pharmacokinetics of Monoclonal Antibodies
Josiah T. Ryman et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells
Braden T. Lobingier et al.
CELL (2017)
Multidimensional Tracking of GPCR Signaling via Peroxidase-Catalyzed Proximity Labeling
Jaeho Paek et al.
CELL (2017)
Molecular basis for the antagonistic activity of an anti-CXCR4 antibody
Li Peng et al.
MABS (2016)
GPCRdb: the G protein-coupled receptor database - an introduction
C. Munk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4
Katherine Griffiths et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 Receptor
Xavier Peyrassol et al.
JOURNAL OF IMMUNOLOGY (2016)
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops
Bas van der Woning et al.
MABS (2016)
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
Sheng-Bin Peng et al.
PLOS ONE (2016)
Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor
Stephanie Hennen et al.
SCIENTIFIC REPORTS (2016)
Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor
Licheng Shi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys
Haruka Okamoto et al.
ENDOCRINOLOGY (2015)
An Immunosuppressive Antibody-Drug Conjugate
Rongsheng E. Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1
Julie A. Douthwaite et al.
MABS (2015)
Potent and Efficacious Inhibition of CXCR2 Signaling by Biparatopic Nanobodies Combining Two Distinct Modes of Action
M. E. Bradley et al.
MOLECULAR PHARMACOLOGY (2015)
A CXCR4-Targeted Site-Specific Antibody-Drug Conjugate
Sumith A. Kularatne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model
Hossein Panjideh et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment
Catherine J. Hutchings et al.
MABS (2014)
Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
Sonia Chamorro et al.
MABS (2014)
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes
Christine J. Rossant et al.
MABS (2014)
Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis
Urs B. Hagemann et al.
PLOS ONE (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
In vitro Fab display: a cell-free system for IgG discovery
Ryan L. Stafford et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Opportunities for functional selectivity in GPCR antibodies
David R. Webb et al.
BIOCHEMICAL PHARMACOLOGY (2013)
BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
Michelle R. Kuhne et al.
CLINICAL CANCER RESEARCH (2013)
Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor
Peter Ravn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo
David Maussang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma
Beatriz Somovilla-Crespo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7
C. Ullmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
De-Kuan Chang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Marketing approval of mogamulizumab A triumph for glyco-engineering
Alain Beck et al.
MABS (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
Thomas Han et al.
PLOS ONE (2012)
Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
Jim Gilbert et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Establishment of a novel monoclonal antibody against LGR5
Yuka Sasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model
Jesper van der Pals et al.
BMC CARDIOVASCULAR DISORDERS (2010)
Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
Toshihiko Ishii et al.
CLINICAL CANCER RESEARCH (2010)
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
Wolfgang Glaesner et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jahnichen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Circular CCR5 peptide conjugates and uses thereof (WO2008074895)
Maja A. Sommerfelt
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients
Jacob Lalezari et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening
Chris de Graaf et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo
Jean-Christophe Peter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Conformation state-sensitive antibodies to G-protein-coupled receptors
Achla Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Interaction between autoantibodies against the β1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes
Torsten Christ et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
beta(1)-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy
R Jahns et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT4) receptor
R Kamel et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Discovery of human antibodies against the C5aR target using phage display technology
LL Huang et al.
JOURNAL OF MOLECULAR RECOGNITION (2005)
An IgM-kappa rat monoclonal antibody specific for the type 1 sphingosine 1-phosphate G protein-coupled receptor with antagonist and agonist activities
EJ Goetzl et al.
IMMUNOLOGY LETTERS (2004)
Ligand channeling within a G-protein-coupled receptor -: The entry and exit of retinals in native opsin
SA Schädel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies
C Blanpain et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans
M Firan et al.
INTERNATIONAL IMMUNOLOGY (2001)
Modulation of beta1-adrenoceptor activity by domain-specific antibodies and-heart failure-associated autoantibodies
R Jahns et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
From agonist to antagonist:: Fab fragments of an agonist-like monoclonal anti-β2-adrenoceptor antibody behave as antagonists
A Mijares et al.
MOLECULAR PHARMACOLOGY (2000)
Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5
T Mirzabekov et al.
NATURE BIOTECHNOLOGY (2000)
A monoclonal antibody directed against an autoimmune epitope on the human β1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy
R Mobini et al.
HYBRIDOMA (2000)
Share Paper
